Drug Target Review2026-07-24T11:50:00
An experimental oral antiviral has demonstrated the ability to prevent both airborne and contact-based transmission of a measles surrogate virus in ferrets, offering a potential new tool to complement vaccination during outbreaks.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-18T15:56:00Z
Contributor Dr Garegin Papoian, Drug Target Review
2026-08-11T07:02:00
Contributor Professor Joseph C. Wu, Drug Target Review
2026-06-04T07:05:00
Author Graham Craig
2026-06-15T07:00:00
Contributor Professor Dipak Ramji, Drug Target Review
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2026-09-01T07:00:00
Sponsored by Promega Corporation
2026-09-17T07:00:00
Contributor Dr Roland Bürli, Dr Francesca Capotosti and Dr Antonella Pirone, Drug Target Review
Site powered by Webvision Cloud